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Abstract
Background: Computed tomography (CT) scans are increasingly available in clinical care globally. They enable a rapid and
detailed assessment of tissue and organ involvement in disease processes that are relevant to diagnosis and management, particularly
in the context of the COVID-19 pandemic.
Objective: The aim of this paper is to identify differences in the CT scan findings of patients who were COVID-19 positive
(confirmed via nucleic acid testing) to patients who were confirmed COVID-19 negative.
Methods: A retrospective cohort study was proposed to compare patient clinical characteristics and CT scan findings in suspected
COVID-19 cases. A multivariable logistic model with LASSO (least absolute shrinkage and selection operator) selection for
variables was used to identify the good predictors from all available predictors. The area under the curve (AUC) with 95% CI
was calculated for each of the selected predictors and the combined selected key predictors based on receiver operating characteristic
curve analysis.
Results: A total of 94 (56%) patients were confirmed positive for COVID-19 from the suspected 167 patients. We found that
elderly people were more likely to be infected with COVID-19. Among the 94 confirmed positive patients, 2 (2%) patients were
admitted to an intensive care unit. No patients died during the study period. We found that the presence, distribution, and location
of CT lesions were associated with the presence of COVID-19. White blood cell count, cough, and a travel history to Wuhan
were also the top predictors for COVID-19. The overall AUC of these selected predictors is 0.97 (95% CI 0.93-1.00).
Conclusions: Taken together with nucleic acid testing, we found that CT scans can allow for the rapid diagnosis of COVID-19.
This study suggests that chest CT scans should be more broadly adopted along with nucleic acid testing in the initial assessment
of suspected COVID-19 cases, especially for patients with nonspecific symptoms.
(JMIR Public Health Surveill 2020;6(4):e19424) doi: 10.2196/19424
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Introduction

Methods

In December 2019, multiple cases of pneumonia were detected
in Wuhan, Hubei Province, China [1]. These patients had
nonspecific symptoms including variable fever, cough, breathing
difficulties, muscle aches, and fatigue. Ultimately, this would
prove to be the seed of a pandemic, named by the World Health
Organization as COVID-19 [2], caused by the seventh member
of the human-infecting coronavirus family, SARS-CoV-2. Other
notable members in the same family are the severe acute
respiratory syndrome (SARS) coronavirus and the Middle East
respiratory syndrome (MERS) coronavirus, which have caused
significant public health hazards. COVID-19 can be transmitted
from person to person through droplets, contact, or through the
fecal-oral route, with a high degree of communicability [3].
Since January 2020, COVID-19 has spread to most parts of
China as well as the world, posing an extensive threat to global
public health by seriously affecting the quality of life of millions
of people. Large numbers of people across China were returning
to their hometown from Wuhan for the Chinese Lunar New
Year [4], making our region a COVID-19 epicenter. This
retrospective study collected consecutively hospitalized patients
with a suspected case of COVID-19 dating to the end of January
2020 at a single tertiary care referral hospital in Zhejiang
Province. As of this writing, the epidemic in this region was
well under control with few new cases and deaths from
COVID-19.

Data Source

In the context of this emergency and the need to move past
nonspecific symptoms to approaches that allow for early
diagnosis and management, we wanted to investigate potential
differences in the chest CT scans of patients who were
COVID-19 positive to those who were COVID-19 negative
(confirmed via nucleic acid test). To demonstrate factors relevant
to clinical outcomes, we wanted to compare patients with a
confirmed positive case of COVID-19 to those with a negative
result based on characteristics, interventions, and outcomes.
This motivated us to propose a retrospective cohort approach
for COVID-19 research. Several case-control studies have been
carried out to investigate the clinical outcome of COVID-19.
For example, several clinical characteristics have been identified
in pregnant women and their neonates with COVID-19 [5].
Furthermore, COVID-19 is known to cause smell and taste
disorders in those who are infected with the disease, particularly
at a higher rate than patients with influenza [6]. However, there
are few retrospective cohort studies that compare patients with
confirmed COVID-19 to suspected cases through chest CT
scans. Therefore, we conducted a retrospective cohort study to
compare clinical characteristics and CT scan findings in
suspected COVID-19 patients. Chest CT scans enable a rapid
and detailed assessment of tissue and organ involvement in
disease processes that are relevant to diagnosis and management,
and so it is important to determine their usage for COVID-19,
particularly since the outbreak of this coronavirus is seriously
affecting people’s lives worldwide.
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In this study, consecutively hospitalized patients with a
suspected case of COVID-19 from January 21, 2020, to February
11, 2020, were identified at a single tertiary care referral hospital
and followed up to the end of April 2020. In the absence of
neutrophilia as an indicator of an alternative diagnosis of
bacterial infection, patients were classified as suspected
COVID-19 cases. Due to isolation care practices, all suspected
COVID-19 patients were assessed in the fever clinic of the
hospital. All suspected COVID-19 patients were included in
this cohort study. Afterward, all suspected COVID-19 patients
underwent physical examinations, including routine blood tests,
C-reactive protein testing, SARS-CoV-2 nucleic acid
examination, and chest CT scans. If the chest CT scan findings
of a patient were abnormal according to the physician, while
the result of nucleic acid examination was negative, then the
patient underwent another nucleic acid examination. Positive
patients who were then confirmed to be infected with
SARS-CoV-2 by nucleic acid testing were transferred to a
special ward for care.
Chest CT scans were performed using a GE Light Speed VCT
64-slice and Phillips Brilliance 16-slice CT. The scanning
parameters used were as follows: tube voltage of 120 kV,
automatic tube current, scanning layer thickness of 5.00 mm,
reconstruction layer thickness of 11.5 mm, image reconstruction
by high-resolution algorithm, and a matrix with 512 × 512 =
262,144 pixels. The lung window had a position of 500
Hounsfield units (HU) and a wider window width of 1500 HU.
The mediastinum window had a position of 40 HU and a
window width of 400 HU. Chest CT scans were focused on
observing the density, number, distribution, location, and
morphology of the lesions, as well as pleural thickening, pleural
effusion, mediastinal lymph node enlargement, or other
accompanying signs. In the early stages, one or two lungs had
many shadows, and there were multiple ground glass density
shadows. The internal lung texture was grid-like with halo signs
around; the long axis of some lesions was parallel to the pleura
and was not distributed according to lung segments. There was
no cavity formation, no pleural effusion, and no significant
swelling of mediastinal lymph nodes. There were also signs of
bronchial ventilation. As the disease progresses, the diseased
area rapidly increased and expanded, advancing from the
periphery to the center along the bronchial vascular bundle, and
may also be distributed in the form of antibutterfly wings.
Therefore, we selected the following 12 CT indicators to better
understand the imaging characteristics and severity of
COVID-19: (1) location of lesions (ie, the left, right, or both
lungs); (2) number of lesions; (3) location of the lesions along
with the bronchus beam distribution, near pleural distribution,
or mixed distribution; (4) lesion(s) size; (5) presence of the air
bronchi sign; (6) presence of grid-like texture; (7) lesion
morphology; (8) percentage of lung involvement; (9) presence
of atelectasis; (10) whether the density of the lesion is
ground-glass–like, solid, or mixed; (11) presence of pleural
effusion, lymphadenopathy, or extrapulmonary manifestations;
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and (12) other potential lung disease features such as pulmonary
bullae, pulmonary nodules, calcifications, and fibrous lesions.

Study Design and Statistical Analysis
We divided all hospitalized patients with suspected COVID-19
in the cohort into either the positive group or the negative group
based on the results of SARS-CoV-2 nucleic acid testing. One
group was COVID-19 positive and the other group was
COVID-19 negative. We wanted to compared patient
epidemiological characteristics as well as clinical laboratory
and CT scan findings in these two groups.
We summarized continuous variables as either means and
standard deviations or medians with interquartile ranges for all
patients in both the positive and negative groups. For categorical
variables, we calculated the percentages of patients in each
category. Characteristics for case and control patients were
compared using the Student t test and analysis of variance, or
nonparametric statistics (rank-sum tests) and chi-square tests
as appropriate. An alpha of .05 was used as the cutoff for
statistical significance. A LASSO (least absolute shrinkage and
selection operator) logistic model for variable selection was
used to identify the key predictors from all available variables.
The area under the curve (AUC) with 95% CIs were calculated
for each of the selected predictors, and the overall AUC of all
these predictors was provided to show the most accurate
combined variables for the biomarkers of COVID-19 from all
available variables in the study. All analyses were done with
SAS software, version 9.4 (SAS Institute Inc).

Ethics Statement

Wu et al
Ethics approval for this project was obtained from the
Institutional Review Board of the University of Nebraska
Medical Center (IRB #1982933).

Results
Patient Epidemiological Characteristics
A total of 167 patients with a suspected case of COVID-19 were
identified and included in the statistical analysis. Their basic
characteristics are shown in Table 1. Patients were aged 1-87
years with a mean age of 44 (SD 19) years; 92 (55%) were men
and 75 (45%) were women. Of these initial 167 suspected
COVID-19 cases, 94 (56%) were confirmed positive, and 38
(23%) had a history of traveling to Wuhan. Comorbidities
varied; 23 (14%) patients had hypertension, 13 (8%) had
diabetes, 13 (8%) had cardiogenic diseases, less than 5 (1%)
had lung disease, less than 5 (1%) had kidney disease, and less
than 5 (1%) had liver disease. Among 123 (74%) patients who
exhibited symptoms, the most common symptoms were fever
(n=123, 74%), cough (n=105, 63%), runny nose (n=22, 13%),
gastrointestinal symptoms (n=22, 13%), sore throat (n=42, 25%),
fatigue (n=32, 19%), and muscle pain (n=31, 19%). In total, 43
(26%) patients had been treated by Chinese medicine, which
includes Lianhua Qingwen capsules and Jinhua Qinggan
granules. Among the 94 patients who were confirmed
COVID-19 positive, 2 (2%) patients were admitted to an
intensive care unit (ICU) during this study. Both ICU patients
were elderly individuals with hypertension or diabetes. No
patients died during the study period.

This was a retrospective case series study, and no patients were
involved in the study design. Therefore, consent was waived.
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Table 1. Epidemiological characteristics of suspected cases of COVID-19.
Characteristic

Total (N=167)

COVID-19 positive (n=94) COVID-19 negative (n=73) P value

Age (years), mean (SD)

44 (19)

47 (14)

38 (23)
<.001

Age category (years) (%)
<18

11

1

23

18-39

27

24

30

40-59

45

57

29

17

18

18

Male (%)

55

60

50

.22

Travel history to Wuhan (%)

23

28

17

.04

14

16

13

.79

≥60

Comorbidities (%)
High blood pressure
Diabetes

8

12

6

.26

Cardiogenic diseases

8

6

8

.88

Lung disease

1

1

0

N/Aa

Anemic

0

0

0

N/A

Stroke

1

1

0

N/A

Kidney disease

0

0

0

N/A

Surgery

11

13

7

.94

Liver disease

0

0

0

N/A

First symptoms at admission (%)
Fever

74

74

75

.65

Cough

63

73

55

.61

Runny nose

13

9

20

.23

Gastrointestinal symptoms

13

14

32

>.99

Sore throat

25

19

25

.48

Fatigue

19

18

18

>.99

Muscle pain

19

26

14

.08

Body temperature, mean (SD)

37.18 (0.79)

37.13 (0.82)

37.27 (0.78)

.07

Pulse, mean (SD)

90 (19)

84 (14)

92 (20)

.003

Respiratory rate, mean (SD)

19.72 (2.47)

19.13 (1.77)

20.25 (3.27)

.005

Blood pressure, mean (SD)

42 (2.13)

47 (14)

38 (23)

<.001

Antivirus

73

75

71

.64

Antibiotics

55

45

68

.002

Hormone

13

22

0

<.001

Chinese medicineb

26

47

0

<.001

Intensive care unit

1

2

0

N/A

Medicine during the hospital (%)

a

N/A: not applicable.

b

Refers to Lianhua Qingwen capsules and Jinhua Qinggan granules.

Biochemical Testing
The results of clinical laboratory testing are summarized in
Table 2. C-reactive protein levels of the confirmed positive
http://publichealth.jmir.org/2020/4/e19424/
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patients (median 8.25, IQR 1.57-15.40) were significantly higher
than those of confirmed negative patients (median 6.75, IQR
1.07-30.19). White blood cell count (median 4.89, IQR
4.05-5.68) was significantly lower in confirmed positive cases
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compared to confirmed negative ones (median 7.99, IQR
5.08-10.03). Similarly, for red blood cell count, the confirmed
positive group had a significantly lower value (median 4.49,
IQR 4.03-4.90). Hemoglobin levels (median 134.20, IQR

Wu et al
108.11-149.23) of confirmed positive patients was significantly
lower than confirmed negative patients (median 139.00, IQR
114.00-150.00).

Table 2. The results of routine blood tests from the clinical laboratory.
Routine blood tests

Total (N=167)

COVID-19 positive (n=94)

COVID-19 negative (n=73) P value

C-reactive protein (mg/L), median
(IQR)

7.10 (1.30-17.50)

8.25 (1.57-15.40)

6.75 (1.07-30.19)

<.001

White blood cell count (109/L), median 5.38 (4.45-7.67)
(IQR)

4.89 (4.05-5.68)

7.99 (5.08-10.03)

<.001

Red blood cell count (109/L), median
(IQR)

4.65 (4.09-5.00)

4.49 (4.03-4.90)

4.78 (4.40-5.08)

.002

Lymphocyte count (109/L), median
(IQR)

1.16 (0.93-1.56)

1.30 (0.96-1.51)

1.11 (0.77-1.66)

.10

Hemoglobin (g/L), median (IQR)

137.24 (109.00-149.00)

134.20 (108.11-149.23)

139.00 (114.00-150.00)

.86

Platelet count (10 /L), median (IQR)

142.00 (59.00-185,00)

145.1 (65.21-180.23)

134.00 (46.00-198.00)

.17

Plasma prothrombin time determination, median (IQR)

13.65 (13.00-13.90)

13.50 (13.10-13.81)

13.80 (10.80-15.15)

<.001

Thrombin time (second), median (IQR) 15.21 (14.45-15.76)

15.10 (14.43-15.70)

15.50 (14.50-16.10)

.54

Activated partial thromboplastin (second), median (IQR)

41.70 (40.00-45.80)

43.46 (40.10-45.60)

41.30 (38.00-46.80)

.003

D-D dimer (µg/ml), median (IQR)

0.45 (0.30-0.70)

0.40 (0.08-0.60)

0.70 (0.44-1.03)

.42

Alanine aminotransferase (IU/L), medi- 28.70 (8.00-45.00)
an (IQR)

33.00 (7.00-40.00)

25.50 (8.00-53.00)

.02

Urea nitrogen (mmol/L), median (IQR) 3.97 (3.39-4.90)

4.03 (3.43-4.66)

3.76 (3.15-6.19)

.19

Fibrinogen (g/L), median (IQR)

4.90 (4.06-5.67)

4.88 (4.07-5.67)

5.03 (3.31-5.90)

.69

Eosinophil count, median (IQR)

0.03 (0.01-0.09)

0.02 (0.01-0.07)

0.04 (0.01-0.11)

<.001

Hematocrit, median (IQR)

0.40 (0.37-0.44)

0.39 (0.36-0.42)

0.41 (0.38-0.45)

.005

9

Chest CT Scans and Imaging
In the first chest CT scan of the 167 patients with a suspected
case of COVID-19, 80 (48%) of the confirmed positive patients
had lesions in both of their lungs compared to 27 (30%) of the
confirmed negative patients. Additionally, 73 (44%) patients
in the positive group had more than three lesions compared to
28 (17%) patients in the negative group. Among the 94
confirmed positive cases, 89 (95%) had patch lesion
morphology. The detailed comparative results are summarized
in Table 3.
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CT scans of 8 randomly selected patients are shown in Figure
1. We found substantial, reliable differences in the chest CT
scans of patients with COVID-19 from those who were
suspected cases confirmed negative via nucleic acid testing.
The dominant phenotype on the CT scan was the presence of
multiple patchy lesions and a distribution of ground glass
shadows in the peripheral pulmonary field, where denser lesions
were large and strip-like with uneven density. Pleural thickening
near affected lung segments was also seen in these patients.
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Table 3. Chest computed tomography (CT) results with lesions and imaging manifestations.
CT image feature

COVID-19 positive (n=94)

COVID-19 negative (n=73)

<.001

Distribution of lesions (%)
No lesions

0

1

Left lung

6

27

Right lung

9

42

Both left and right lungs

85

30
<.001

Number of lesions (%)
1

9

46

2

9

16

≥3

81

38

Distributed along the bronchogram

11

15

Close to the pleura

50

30

Mixed distribution

39

55

.01

Locations of lesions (%)

<.001

Size of lesion (cm) (%)
<1

11

37

1-3

26

28

>3

63

34
<.001

Air bronchogram sign (%)
Yes

17

11

No

83

89
<.001

Lesions’ internal texture (%)
Lattice texture

28

22

No lattice texture

72

78
.003

Lesion morphology (%)
Patch

95

37

Pulmonary segments

2

26

Lobe involvement

3

37
<.001

Lung involvement (%)
<25%

59

73

50%-75%

28

22

>75%

16

5
<.001

Atelectasis (%)
Yes

2

8

No

98

91
.001

Lesion density (%)
None

3

1

Ground glass

23

19

Solid

3

29

Mixed

71

51
<.001

Extrapulmonary manifestations (%)
Pleural effusion

3

1

Lymphadenopathy

3

12
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CT image feature
None

Wu et al
COVID-19 positive (n=94)

COVID-19 negative (n=73)

94

87

Other lung diseases including bullae, pulmonary nodule, fibrous stove, calcification, and tuberculosis (%)
Yes

33

22

No

67

78

P value

<.001

Figure 1. The images in the left panel are CT scans of four randomly selected confirmed COVID-19–positive patients. There are multiple patchy
lesions, and the grinding glass shadows are distributed in the peripheral pulmonary field. The images in the right panel are CT scans of four randomly
selected suspected patients who were confirmed to be COVID-19 negative. Their lesions are large, strip-like, and have uneven density. Pleural thickening
near affected lung segments is also seen.

Multivariable Analysis
A multivariable LASSO logistic model for variable selection
was used to identify the key predictors from all variables in
Tables 1-3. We found the key predictors for COVID-19 to be
white blood cell count, lesion morphology, distribution of
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lesions, cough, locations of lesions, and travel history to Wuhan.
The AUC for each of the selected predictors ranged from 0.56
to 0.80, as shown in Table 4. The overall AUC of all these
selected key predictors was 0.97 (95% CI 0.93-1.00), as shown
in Figure 2.
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Table 4. Area under the curve (AUC) values for the selected predictors from the logistic model with LASSO (least absolute shrinkage and selection
operator) selection.
Selected variables

AUC (95% CI)

White blood cell count

0.80 (0.72-0.87)

Lesion morphology

0.78 (0.71-0.84)

Distribution of lesions

0.76 (0.69-0.84)

Cough

0.59 (0.52-0.66)

Locations of lesions

0.56 (0.47-0.65)

Travel history to Wuhan

0.55 (0.48-0.61)

Overall AUC of the above selected variables

0.97 (0.93-1.00)

Figure 2. The receiver operating characteristic (ROC) curve of selected variables for COVID-19–positive cases. The ROC curve demonstrates the
trade-off between sensitivity and specificity, and shows that the biomarker with a combination of selected variables is the most accurate test for identifying
patients with COVID-19 due to an area under the curve (AUC) value of 0.97 (95% CI 0.93-1.00).

Discussion
This retrospective cohort study described the differences in
clinical characteristics between patients who were confirmed
COVID-19 positive to those confirmed to be COVID-19
negative. Elderly people were more likely to be infected by
COVID-19. We also found significant associations between
low white blood cell count, high C-reactive protein, and a
subsequent positive COVID-19 test. Regarding the low white
blood count, this is common in viral infections and is of a larger
magnitude than the absence of leukocytosis. Fever symptoms
http://publichealth.jmir.org/2020/4/e19424/
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are the first clinical characteristics, alongside gastrointestinal
reactions, sore throat, fatigue, and muscle pain. However, many
patients (n=24, 26%) did not have a fever and cough. Of the
original 167 suspected patients, 6 (4%) were negative according
to the results of their first nucleic acid test, but they were
consequently confirmed positive after performing CT chest
scans. Chest CT scans can supply a better understanding of
COVID-19, especially for patients with no specific symptoms,
such as fever and cough.
While other studies have begun to describe clinical experiences
of this novel disease, our patients had not yet been described
JMIR Public Health Surveill 2020 | vol. 6 | iss. 4 | e19424 | p. 8
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nor this question addressed [7]. For example, laboratory
examination showed normal or decreased peripheral white blood
cells, and CT scan findings showed that the locations of lesions
are more likely to be close to the pleura. Compared with the
clinical outcomes of other studies [8-11], fewer patients (less
than 5%) were admitted to an intensive care unit in our study,
and no patients died during the study period. More importantly,
few studies have provided a comparison of patients who were
confirmed COVID-19 positive to those who were confirmed
COVID-19 negative. Therefore, one strength of this paper is
that we can clearly show the differences between confirmed
positive and confirmed negative patients through our
retrospective cohort design. The comparative results can provide
some valuable information in the understanding of the clinical
features of COVID-19 to help identify patients who have the
coronavirus from a large group of patients who may or may not
be infected. This is especially applicable to current times since
the number of people suspected to be infected with the disease
is increasing rapidly worldwide. Another strength of this paper
is that we could identify the top key predictors from all
predictors based on the multivariable LASSO logistic model.
The area under the multivariable receiver operating characteristic
(ROC) curve (0.97, 95% CI 0.93-1.00) illustrates that the
combined biomarker of these selected key predictors is a good

Wu et al
index for COVID-19. However, this study has some inherent
limitations as a retrospective cohort study. For example, we did
not have additional laboratory or lung function data to measure
immune responses. This retrospective study lacks a formal
sample size and power calculations. The power of this study
may be limited due to the relatively small number of infected
patients with chest CT scans; the study also took place at a
single tertiary care referral hospital. The results need to be
replicated with a larger number of COVID-19–confirmed cases
in future studies.
With our well-characterized patients, this retrospective cohort
study can enhance our understanding of the use of chest CT
scans for COVID-19 case management. For example, we found
that the early signs of CT lesions are in both lungs, and locations
of lesions are more likely to be close to the pleura. We also
observed that the lesion distribution gradually expands from
the periphery to the center, and the lesion density is more
inclined to be mixed. Therefore, chest CT scans should be more
broadly adopted along with nucleic acid testing in the initial
assessment of suspected COVID-19 cases when the nucleic acid
examination is delayed or negative, or when further clinical
characterization of severity is needed, especially for patients
with nonspecific symptoms.
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